The vaginal microbiome and HIV acquisition risk

Area of Science:

• Reproductive Health
• Microbiome Research
• Infectious Disease Epidemiology

Background:

• Non-optimal vaginal microbiomes, vulvovaginal candidiasis, and STIs are linked to higher HIV acquisition risk.
• Significant knowledge gaps exist regarding the vaginal microbiome's role in HIV risk, particularly non-bacterial components.
• The functional host-microbiome interactions increasing HIV acquisition risk are not fully understood.

Purpose of the Study:

• To highlight the critical need for improved understanding and characterization of the vaginal microbiome in relation to HIV acquisition.
• To emphasize the necessity for developing accessible diagnostics and therapeutics for vaginal microbiome dysbiosis.
• To underscore the importance of clinically evaluating interventions targeting the vaginal microbiome for HIV risk reduction.

Main Methods:

• Review of clinical studies associating vaginal bacteriomes and infections with HIV risk.
• Discussion of advanced omics technologies for microbiome characterization.
• Mention of improved in-vitro models simulating the female genital tract environment.

Main Results:

• Established link between non-optimal vaginal bacteriomes and increased HIV acquisition risk.
• Identified gaps in understanding non-bacterial microbiome components and host interactions.
• Highlighted the need for resource-feasible diagnostics and therapeutics.

Conclusions:

• Further research and investment are essential to address the role of the vaginal microbiome in women's HIV acquisition.
• Development of effective vaginal microbiome interventions requires advanced technologies and clinical evaluation.
• Addressing vaginal microbiome health is a critical component of women's health and HIV prevention strategies.